Gabanan, Dan B.
HRN: 25-85-73 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2024
CO-AMOXICLAV 625MG (TAB)
09/15/2024
09/22/2024
PER OREM
1tab
BID
UTI Complicated
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes